Difficulty: Medium
Average Score: 89%
Practice
Which of the following statements is correct?
Correct answer
C
Rationale
In pharmacology, Monoamine oxidase (MAO) enzymes play a crucial role in the metabolism of neurotransmitters like norepinephrine, dopamine, and serotonin. The correct answer is C) MAO-A metabolizes norepinephrine and serotonin; MAO-B metabolizes dopamine.
MAO-A primarily metabolizes norepinephrine and serotonin, while MAO-B mainly metabolizes dopamine. Understanding this distinction is essential in pharmacology, as drugs targeting MAO-A or MAO-B can have different effects based on the neurotransmitter they predominantly act upon.
Option A is incorrect because MAO-A metabolizes norepinephrine and serotonin, not dopamine. Option B is incorrect because MAO-A metabolizes norepinephrine and serotonin, not dopamine. Option D is incorrect because MAO-B metabolizes dopamine, not norepinephrine and serotonin.
Educationally, knowing the specific roles of MAO-A and MAO-B in neurotransmitter metabolism is vital for healthcare professionals prescribing medications affecting these pathways. Understanding these distinctions can help prevent adverse drug reactions and optimize therapeutic outcomes across different patient populations.
MAO-A primarily metabolizes norepinephrine and serotonin, while MAO-B mainly metabolizes dopamine. Understanding this distinction is essential in pharmacology, as drugs targeting MAO-A or MAO-B can have different effects based on the neurotransmitter they predominantly act upon.
Option A is incorrect because MAO-A metabolizes norepinephrine and serotonin, not dopamine. Option B is incorrect because MAO-A metabolizes norepinephrine and serotonin, not dopamine. Option D is incorrect because MAO-B metabolizes dopamine, not norepinephrine and serotonin.
Educationally, knowing the specific roles of MAO-A and MAO-B in neurotransmitter metabolism is vital for healthcare professionals prescribing medications affecting these pathways. Understanding these distinctions can help prevent adverse drug reactions and optimize therapeutic outcomes across different patient populations.